Coeptis Therapeutics Holdings, Inc.
COEP
$9.75
$0.272.85%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.76M | 9.26M | 10.04M | 14.32M | 15.19M |
| Depreciation & Amortization | 500.00K | 500.00K | 500.00K | 500.00K | 500.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.26M | 17.02M | 17.87M | 21.49M | 21.34M |
| Operating Income | -11.26M | -17.02M | -17.87M | -21.49M | -21.34M |
| Income Before Tax | -11.62M | -16.14M | -16.31M | -21.27M | -20.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.62 | -16.14 | -16.31 | -21.27 | -20.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.62M | -16.14M | -16.31M | -21.27M | -20.45M |
| EBIT | -11.26M | -17.02M | -17.87M | -21.49M | -21.34M |
| EBITDA | -10.26M | -16.02M | -16.87M | -20.49M | -20.34M |
| EPS Basic | -6.44 | -10.29 | -11.61 | -17.84 | -18.88 |
| Normalized Basic EPS | -4.01 | -6.43 | -7.26 | -11.15 | -11.96 |
| EPS Diluted | -6.44 | -10.29 | -11.61 | -17.84 | -18.88 |
| Normalized Diluted EPS | -4.01 | -6.43 | -7.26 | -11.15 | -11.96 |
| Average Basic Shares Outstanding | 7.34M | 6.68M | 5.89M | 5.12M | 4.33M |
| Average Diluted Shares Outstanding | 7.34M | 6.68M | 5.89M | 5.12M | 4.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
